Shares of Dynatronics Co. (NASDAQ:DYNT) have earned an average rating of “Buy” from the six ratings firms that are currently covering the firm, MarketBeat.com reports. One equities research analyst has rated the stock with a hold recommendation and four have issued a buy recommendation on the company. The average twelve-month target price among brokerages that have updated their coverage on the stock in the last year is $2.58.
A number of research analysts have issued reports on DYNT shares. Maxim Group set a $3.00 target price on shares of Dynatronics and gave the stock a “buy” rating in a research report on Thursday, September 26th. ValuEngine upgraded shares of Dynatronics from a “sell” rating to a “hold” rating in a research report on Tuesday. Finally, Zacks Investment Research upgraded shares of Dynatronics from a “hold” rating to a “buy” rating and set a $0.75 target price on the stock in a research report on Tuesday, November 26th.
DYNT remained flat at $$0.73 on Wednesday. 10,482 shares of the company were exchanged, compared to its average volume of 12,878. Dynatronics has a twelve month low of $0.65 and a twelve month high of $2.88. The firm has a market cap of $6.46 million, a PE ratio of -3.48 and a beta of 0.02. The firm’s fifty day simple moving average is $0.80 and its two-hundred day simple moving average is $1.27. The company has a debt-to-equity ratio of 0.59, a quick ratio of 0.59 and a current ratio of 1.36.
Dynatronics (NASDAQ:DYNT) last announced its earnings results on Tuesday, November 12th. The medical equipment provider reported ($0.01) earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.04) by $0.03. Dynatronics had a negative net margin of 1.84% and a negative return on equity of 12.16%. The firm had revenue of $16.39 million for the quarter, compared to analyst estimates of $16.21 million. Research analysts forecast that Dynatronics will post -0.13 earnings per share for the current fiscal year.
A hedge fund recently raised its stake in Dynatronics stock. Vanguard Group Inc. boosted its stake in Dynatronics Co. (NASDAQ:DYNT) by 76.4% in the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 50,484 shares of the medical equipment provider’s stock after purchasing an additional 21,870 shares during the quarter. Vanguard Group Inc. owned about 0.60% of Dynatronics worth $83,000 as of its most recent SEC filing. 11.70% of the stock is owned by hedge funds and other institutional investors.
Dynatronics Corporation designs, manufactures, markets, and distributes orthopedic soft goods, medical supplies, and physical therapy and rehabilitation equipment in the United States and internationally. It offers ankle and wrist braces, hot packs, cold packs, lumbar rolls, cervical collars, slings, cervical pillows, bolsters, positioning wedges, back cushions, lotions and gels, paper products, athletic tape, splints, elastic wraps, exercise weights, exercise bands and tubing, electrodes, and rehabilitation and back products.
See Also: Strike Price
Receive News & Ratings for Dynatronics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dynatronics and related companies with MarketBeat.com's FREE daily email newsletter.